SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-04-002486
Filing Date
2004-05-07
Accepted
2004-05-07 15:31:33
Documents
5
Period of Report
2004-03-31

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS, INC. b50319aie10vq.htm 10-Q 228059
2 EX-10.1 FIRST AMENDMENT OF LEASE 8-15-03 b50319aiexv10w1.txt EX-10.1 9855
3 EX-31.1 CERTIFICATION OF CEO PURSUANT TO SEC 302 b50319aiexv31w1.htm EX-31.1 7116
4 EX-31.2 CERTIFICATION OF CFO PURSUANT TO SEC 302 b50319aiexv31w2.htm EX-31.2 7097
5 EX-32.1 CERTIFICATION OF CEO/CFO PURSUANT TO 1350 b50319aiexv32w1.htm EX-32.1 2791
  Complete submission text file 0000950135-04-002486.txt   257038
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29089 | Film No.: 04789032
SIC: 2836 Biological Products, (No Diagnostic Substances)